A Comparison of Podocyturia, Albuminuria and Nephrinuria in Predicting the Development of Preeclampsia: A Prospective Study

L Duley, 2009, The global impact of pre-eclampsia and eclampsia, Semin Perinatol, 33, 130, 10.1053/j.semperi.2009.02.010

RJ Levine, 2006, Soluble endoglin and other circulating antiangiogenic factors in preeclampsia, N Engl J Med, 355, 992, 10.1056/NEJMoa055352

A Hertig, 2004, Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia, Clin Chem, 50, 1702, 10.1373/clinchem.2004.036715

BM Polliotti, 2003, Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia, Obstet Gynecol, 101, 1266

RJ Levine, 2006, Soluble endoglin and other circulating antiangiogenic factors in preeclampsia, N Engl J Med, 355, 992, 10.1056/NEJMoa055352

S Rana, 2007, Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia, Hypertension, 50, 137, 10.1161/HYPERTENSIONAHA.107.087700

Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, <etal>et al</etal>.. (2007) Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol 196: 239 e231–236.

U Qazi, 2008, Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus, J Rheumatol, 35, 631

A Rolfo, 2013, Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers, Kidney Int, 83, 177, 10.1038/ki.2012.348

U Perni, 2012, Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy, Hypertension, 59, 740, 10.1161/HYPERTENSIONAHA.111.181735

S Polsani, 2013, Emerging new biomarkers of preeclampsia, Adv Chronic Kidney Dis, 20, 271, 10.1053/j.ackd.2013.01.001

VD Garovic, 2007, Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia, Nephrol Dial Transplant, 22, 1136, 10.1093/ndt/gfl711

Garovic VD, Wagner SJ, Turner ST, Rosenthal DW, Watson WJ, et al. (2007) Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 196: 320 e321–327.

B Jim, 2012, Podocyturia as a Diagnostic Marker for Preeclampsia amongst High-Risk Pregnant Patients, J Pregnancy, 2012, 984630

IM Craici, 2013, Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study, Hypertension, 61, 1289, 10.1161/HYPERTENSIONAHA.113.01115

SE Maynard, 2003, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, J Clin Invest, 111, 649, 10.1172/JCI17189

M Camici, 2008, Urinary biomarkers of podocyte injury, Biomark Med, 2, 613, 10.2217/17520363.2.6.613

Kelder TP, Penning ME, Uh HW, Cohen D, Bloemenkamp KW, <etal>et al</etal>.. (2012) Quantitative Polymerase Chain Reaction-Based Analysis of Podocyturia Is a Feasible Diagnostic Tool in Preeclampsia. Hypertension.

K Aita, 2009, Acute and transient podocyte loss and proteinuria in preeclampsia, Nephron Clin Pract, 112, c65, 10.1159/000213083

T Sakairi, 2010, Conditionally immortalized human podocyte cell lines established from urine, Am J Physiol Renal Physiol, 298, F557, 10.1152/ajprenal.00509.2009

SU Vogelmann, 2003, Urinary excretion of viable podocytes in health and renal disease, Am J Physiol Renal Physiol, 285, F40, 10.1152/ajprenal.00404.2002

T Nakamura, 2000, Urinary excretion of podocytes in patients with diabetic nephropathy, Nephrol Dial Transplant, 15, 1379, 10.1093/ndt/15.9.1379

S Rana, 2014, Angiogenic factors in diagnosis, management, and research in preeclampsia, Hypertension, 63, 198, 10.1161/HYPERTENSIONAHA.113.02293